세계의 인터벤션 이미징 시장 규모 조사 : 예측, 제품별, 용도별, 최종사용자별, 지역별 전망(2022-2032년)

The Global Interventional Imaging Market is valued at approximately USD 9.24 billion in 2023 and is anticipated to grow with a healthy growth rate of over 6.71% over the forecast period 2024-2032. Interventional imaging is the use of various imaging technologies to guide minimally invasive surgical procedures and diagnostic interventions. This technique is integral to interventional radiology, where imaging modalities such as X-ray, ultrasound, CT (computed tomography), and MRI (magnetic resonance imaging) are used to visualize the inside of the body in real time. This allows physicians to accurately guide instruments through small incisions or natural body openings to diagnose or treat medical conditions.

The increasing demand for minimally invasive procedures, coupled with the growing adoption of new technologies and the rising prevalence of chronic diseases, are significant factors driving the expansion of the Interventional Imaging Market. This market includes various procedures, consumables, systems, and software designed for the diagnosis and treatment of chronic diseases, making it a cornerstone in the evolution of medical diagnostics and treatment. Recent years have witnessed notable improvements and innovations in imaging technologies, particularly with the advent of 3D and 4D imaging and high-quality 4K imaging systems. These advancements have transformed the market, offering faster, more efficient, and cost-effective imaging solutions that enhance patient care and treatment outcomes. Interventional imaging technology has not only supported but catalyzed numerous breakthroughs in both diagnosis and treatment, promising more revolutionary findings in the future.

The key regions considered in the study of Global Interventional Imaging Market include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa Regionally, North America held the dominating position in 2023, owing to factors such as the increasing prevalence of chronic diseases such as cardiovascular diseases, cancer, and neurological disorders necessitates advanced diagnostic and therapeutic procedures, boosting the demand for interventional imaging. Moreover, technological advancements in imaging modalities, such as the development of high-resolution and 3D imaging systems, enhance the precision and effectiveness of minimally invasive procedures, attracting healthcare providers to adopt these technologies. Additionally, the rising geriatric population, which is more susceptible to chronic conditions, contributes to the growing demand for interventional imaging. while the Asia-Pacific region is expected to register the fastest growth during the forecast period 2024-2032. The economic growth in countries like China and India, coupled with increasing healthcare spending and technological advancements, presents substantial opportunities for market expansion in the Asia-Pacific region.

Major market players included in this report are:

• Becton, Dickinson and Company
• Canon Inc.
• Esaote SpA
• FUJIFILM Holdings Corporation
• GE HealthCare
• Hologic, Inc.
• Intuitive Surgical, Inc.
• Koninklijke Philips NV
• Medtronic plc
• Siemens Healthineers AG
• Stryker Corporation
• Shimadzu Corporation
• Terumo Corporation
• Trivitron Healthcare
• Hitachi Medical Systems

The detailed segments and sub-segment of the market are explained below:

By Offering:

• Interventional Imaging Systems
• Interventional Imaging Software
• Consumables

By Application:

• Cardiology
• Neurology
• Musculoskeletal
• Oncology
• Urology
• Gastroenterology
• Obstetrics
• Gynaecology
• Others

By End User:

• Hospitals
• Ambulatory Surgical Centres
• Clinics

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Interventional Imaging Market Executive Summary

• 1.1. Global Interventional Imaging Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Offering
  • 1.3.2. By Application
  • 1.3.3. By End User
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Interventional Imaging Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Interventional Imaging Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Increasing Demand for Minimally Invasive Procedures
  • 3.1.2. Technological Advancements in Imaging
  • 3.1.3. Prevalence of Chronic Diseases
• 3.2. Market Challenges
  • 3.2.1. Shortage of Skilled Professionals
  • 3.2.2. High Costs of Advanced Imaging Systems
• 3.3. Market Opportunities
  • 3.3.1. Integration of AI in Imaging
  • 3.3.2. Expanding Healthcare Infrastructure in Emerging Economies
  • 3.3.3. Increasing Adoption of 3D and 4D Imaging

Chapter 4. Global Interventional Imaging Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Interventional Imaging Market Size & Forecasts by Offering 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Interventional Imaging Market: Offering Revenue Trend Analysis, 2022 & 2032(USD Billion)
  • 5.2.1. Interventional Imaging Systems
  • 5.2.2. Interventional Imaging Software
  • 5.2.3. Consumables

Chapter 6. Global Interventional Imaging Market Size & Forecasts by Application 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Interventional Imaging Market: Application Revenue Trend Analysis, 2022 & 2032(USD Billion)
  • 6.2.1. Cardiology
  • 6.2.2. Neurology
  • 6.2.3. Musculoskeletal
  • 6.2.4. Oncology
  • 6.2.5. Urology
  • 6.2.6. Gastroenterology
  • 6.2.7. Obstetrics
  • 6.2.8. Gynaecology
  • 6.2.9. Others

Chapter 7. Global Interventional Imaging Market Size & Forecasts by End User 2022-2032

• 7.1. Segment Dashboard
• 7.2. Global Interventional Imaging Market: End User Revenue Trend Analysis, 2022 & 2032(USD Billion)
  • 7.2.1. Hospitals
  • 7.2.2. Ambulatory Surgical Centres
  • 7.2.3. Clinics

Chapter 8. Global Interventional Imaging Market Size & Forecasts by Region 2022-2032

• 8.1. North America Interventional Imaging Market
  • 8.1.1. U.S. Interventional Imaging Market
    • 8.1.1.1. Offering breakdown size & forecasts, 2022-2032
    • 8.1.1.2. Application breakdown size & forecasts, 2022-2032
    • 8.1.1.3. End User breakdown size & forecasts, 2022-2032
  • 8.1.2. Canada Interventional Imaging Market
    • 8.1.2.1. Offering breakdown size & forecasts, 2022-2032
    • 8.1.2.2. Application breakdown size & forecasts, 2022-2032
    • 8.1.2.3. End User breakdown size & forecasts, 2022-2032
• 8.2. Europe Interventional Imaging Market
  • 8.2.1. UK Interventional Imaging Market
  • 8.2.2. Germany Interventional Imaging Market
  • 8.2.3. France Interventional Imaging Market
  • 8.2.4. Italy Interventional Imaging Market
  • 8.2.5. Spain Interventional Imaging Market
  • 8.2.6. Rest of Europe Interventional Imaging Market
• 8.3. Asia Pacific Interventional Imaging Market
  • 8.3.1. China Interventional Imaging Market
  • 8.3.2. India Interventional Imaging Market
  • 8.3.3. Japan Interventional Imaging Market
  • 8.3.4. Australia Interventional Imaging Market
  • 8.3.5. Rest of Asia Pacific Interventional Imaging Market
• 8.4. Latin America Interventional Imaging Market
  • 8.4.1. Brazil Interventional Imaging Market
  • 8.4.2. Mexico Interventional Imaging Market
  • 8.4.3. Rest of Latin America Interventional Imaging Market
• 8.5. Middle East & Africa Interventional Imaging Market
  • 8.5.1. Saudi Arabia Interventional Imaging Market
  • 8.5.2. South Africa Interventional Imaging Market
  • 8.5.3. Rest of Middle East & Africa Interventional Imaging Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Becton, Dickinson and Company
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Market Strategies
  • 9.3.2. Canon Inc.
  • 9.3.3. Esaote SpA
  • 9.3.4. FUJIFILM Holdings Corporation
  • 9.3.5. GE HealthCare
  • 9.3.6. Hologic, Inc.
  • 9.3.7. Intuitive Surgical, Inc.
  • 9.3.8. Koninklijke Philips NV
  • 9.3.9. Medtronic plc
  • 9.3.10. Siemens Healthineers AG
  • 9.3.11. Stryker Corporation
  • 9.3.12. Shimadzu Corporation
  • 9.3.13. Terumo Corporation
  • 9.3.14. Trivitron Healthcare
  • 9.3.15. Hitachi Medical Systems

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes